Stock LBPH LONGBOARD PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Longboard Pharmaceuticals, Inc.

Equities

LBPH

US54300N1037

Market Closed - Nasdaq
Other stock markets
 21:30:01 06/05/2024 BST 		5-day change 1st Jan Change
20.6 USD -3.63% Intraday chart for Longboard Pharmaceuticals, Inc. -2.97% +241.63%
05-03 Wedbush Adjusts Longboard Pharmaceuticals' PT to $34 From $32, Keeps Outperform Rating MT
05-02 Longboard Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
LONGBOARD PHARMACEUTICALS, INC. Stock Longboard Pharmaceuticals, Inc.
 801M - - - - -
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 106B
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 104B
ARGENX SE Stock argenx SE
 23.25B -
BIONTECH SE Stock BioNTech SE
 22.5B -
GENMAB A/S Stock Genmab A/S
 18.7B
  1. Stock Market
  2. Equities
  3. LBPH Stock
  4. Charts Longboard Pharmaceuticals, Inc.
  5. Sector Chart